Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Jean-Luc Breau"'
Autor:
Christine Lagorce, Olivier Rixe, Antoine Martin, A. Tadlaoui Hbibi, J-P. Spano, Remi Fagard, Jean-Luc Breau, Robert Benamouzig, G. Des Guetz, G. Milano, Philippe Wind, J.-F. Morere
Publikováno v:
Europe PubMed Central
Aims: The Epidermal Growth Factor-Receptor (EGF-R) is frequently overexpressed in colorectal carcinoma (CRC) and patients can benefit from anti-EGF-R therapy. Yet, the relationship, within tumours, between EGF-R and the activity of downstream effecto
Publikováno v:
Targeted Oncology. 2:49-57
The presence of lymph node metastasis is predictive of poor prognosis in solid tumors. Demonstration of specific markers of lymphatic endothelial cells has facilitated the study of the molecular mechanisms of metastasis, particularly lymphangiogenesi
Autor:
Patrick Nicolas, G. Des Guetz, Gérard-Yves Perret, Bernard Uzzan, Jean-Luc Breau, J.-F. Morere, Robert Benamouzig, M. Cucherat
Publikováno v:
British Journal of Cancer
We performed a meta-analysis of all published studies relating intratumoural microvessel density (MVD) (45 studies) or vascular endothelial growth factor (VEGF) expression (27 studies), both reflecting angiogenesis, to relapse free (RFS) and overall
Autor:
Olivier Bouché, Jean-François Seitz, J. M. Tigaud, Valérie Boige, Roland Bugat, Jean-Luc Breau, Philippe Rougier, Pierre-Luc Etienne, Francois Morvan, Emmanuel Mitry, Mahmoud Ould-Kaci, Esteban Cvitkovic, Michel Ducreux
Publikováno v:
Gastroentérologie Clinique et Biologique. 30:357-363
Resume Objectifs — L’efficacite et le benefice d’une chimiotherapie de seconde ligne dans le traitement des adenocarcinomes pancreatiques n’ont jamais ete demontres bien que ce traitement soit regulierement prescrit. Malades et methodes — U
Publikováno v:
Gastroentérologie Clinique et Biologique. 29:411-414
Autor:
Marie-Ange Massiani, Jean-Luc Breau, David Khayat, Sylvie Friard, Christine Katlama, Jean-François Morère, Philippe Bossi, Olivier Rixe, Louis-Jean Couderc, François Rouges, Michele Bentata, Jean-Philippe Spano
Publikováno v:
Medical Oncology. 21:109-116
The improved survival of patients since the use of highly active antiretroviral treatments has lead to the reporting of non-AIDS defining tumors, such as lung cancer.Analysis of the records of 22 HIV-infected patients with lung cancer (LC) diagnosed
Autor:
Jean-Luc Breau, Jean-Philippe Vuillez, Denis Moro, Jean-Loup Romet-Lemonne, Manuel Lopez, Jean-Christophe Eymard, Mohamed Chokri, Isabelle Monnet, Hervé Lena, Olivier Menard
Publikováno v:
Chest. 121:1921-1927
Study objectives Intrapleural immunotherapy has shown some activity in patients with malignant mesothelioma. We conducted a multicentric pilot phase II study to evaluate the tolerance and the activity of intrapleurally infused autologous human activa
Publikováno v:
European Journal of Internal Medicine. 13:227-232
HIV-infected patients are at an increased risk for developing cancers. Three, in particular, are considered to be AIDS-defining malignancies: Kaposi's sarcoma (KS), non-Hodgkin's lymphoma (NHL), and cervical cancer. Other non-AIDS-defining malignanci
Autor:
Catherine Boaziz, Kohn M, Jean-Luc Breau, A Brunet, Thierry Bouillet, Jean-François Morère, S Piperno-Neumann
Publikováno v:
Lung Cancer. 18:95-100
Purpose : The study assessed the efficacy of combination therapy with vinorelbine and ifosfamide in patients with unresectable non-small cell lung cancer. Patients and methods : Forty patients with non-small cell lung cancer whose tumour was unresect
Autor:
Jean-François Morère, E. Haddad, T. Bouillet, J.J. Mazeron, C. Boaziz, S. Piperno-Neuman, Jean-Luc Breau
Publikováno v:
Cancer/Radiothérapie. 1:121-131
Resume But de l'etude Determiner l'efficacite et la tolerance d'une chimiotherapie d'induction suivie d'une association concomitante de radiotherapie et chimiotherapie dans le traitement du cancer bronchique non a petites cellules de stade III et rec